Browse > Article
http://dx.doi.org/10.14348/molcells.2015.2229

Galangin and Kaempferol Suppress Phorbol-12-Myristate-13-Acetate-Induced Matrix Metalloproteinase-9 Expression in Human Fibrosarcoma HT-1080 Cells  

Choi, Yu Jung (Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University)
Lee, Young Hun (Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University)
Lee, Seung-Taek (Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University)
Abstract
Matrix metalloproteinase (MMP)-9 degrades type IV collagen in the basement membrane and plays crucial roles in several pathological implications, including tumorigenesis and inflammation. In this study, we analyzed the effect of flavonols on MMP-9 expression in phorbol-12-myristate-13-acetate (PMA)-induced human fibrosarcoma HT-1080 cells. Galangin and kaempferol efficiently decreased MMP-9 secretion, whereas fisetin only weakly decreased its secretion. Galangin and kaempferol did not affect cell viability at concentrations up to $30{\mu}M$. Luciferase reporter assays showed that galangin and kaempferol decrease transcription of MMP-9 mRNA. Moreover, galangin and kaempferol strongly reduce $I{\kappa}B{\alpha}$ phosphorylation and significantly decrease JNK phosphorylation. These results indicate that galangin and kaempferol suppress PMA-induced MMP-9 expression by blocking activation of NF-${\kappa}B$ and AP-1. Therefore, these flavonols could be used as chemopreventive agents to lower the risk of diseases involving MMP-9.
Keywords
flavonol; galangin; kaempferol; mitogen-activated protein kinase; MMP-9; NF-${\kappa}B$;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Chen, H.J., Lin, C.M., Lee, C.Y., Shih, N.C., Peng, S.F., Tsuzuki, M., Amagaya, S., Huang, W.W., and Yang, J.S. (2013). Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells. Oncol. Rep. 30, 925-932.   DOI
2 Coussens, L.M., Fingleton, B., and Matrisian, L.M. (2002). Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392.   DOI   ScienceOn
3 Gum, R., Wang, H., Lengyel, E., Juarez, J., and Boyd, D. (1997). Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14, 1481-1493.   DOI
4 Hah, N., and Lee, S.T. (2003). An absolute role of the PKCdependent NF-kappaB activation for induction of MMP-9 in hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 305, 428-433.   DOI   ScienceOn
5 Hanneken, A., Lin, F.F., Johnson, J., and Maher, P. (2006). Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death. Invest. Ophthalmol. Vis. Sci. 47, 3164-3177.   DOI   ScienceOn
6 Kim, H.I., Saldova, R., Park, J.H., Lee, Y.H., Harvey, D.J., Wormald, M.R., Wynne, K., Elia, G., Kim, H.-J., Rudd, P.M., and Lee, S.-T. (2013) The presence of outer arm fucose residues on the Nglycans of tissue inhibitor of metalloproteinases-1 reduces its activity. J. Proteome Res. 12, 3547-3560.   DOI   ScienceOn
7 Knekt, P., Kumpulainen, J., Jarvinen, R., Rissanen, H., Heliovaara, M., Reunanen, A., Hakulinen, T., and Aromaa, A. (2002). Flavonoid intake and risk of chronic diseases. Am. J. Clin. Nutr. 76, 560-568.   DOI
8 Lee, D.E., Chung, M.Y., Lim, T.G., Huh, W.B., Lee, H.J., and Lee, K.W. (2013). Quercetin suppresses intracellular ROS formation, MMP activation, and cell motility in human fibrosarcoma cells. J. Food Sci. 78, H1464-1469.   DOI   ScienceOn
9 Lee, S.U., Ahn, K.S., Sung M.H., Park, J.W., Ryu, H.W., Lee, H.J., Hong, S.T., and Oh, S.R. (2014). Indacaterol inhibits tumor cell invasiveness and MMP-9 expression by suppressing IKK/NF-${\kappa}B$ activation. Mol. Cells 37, 585-591.   DOI   ScienceOn
10 Lianxu, C., Hongti, J., and Changlong, Y. (2006). NF-kappaBp65- specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes. Osteoarthritis Cartilage 14, 367-376.   DOI   ScienceOn
11 Lin, C.W., Shen, S.C., Chien, C.C., Yang, L.Y., Shia, L.T., and Chen, Y.C. (2010). 12-O-tetradecanoylphorbol-13-acetate-induced invasion/ migration of glioblastoma cells through activating PKCalpha/ ERK/NF-kappaB-dependent MMP-9 expression. J. Cell Physiol. 225, 472-481.   DOI   ScienceOn
12 Lin, C.W., Chen, P.N., Chen, M.K., Yang, W.E., Tang, C.H., Yang, S.F., and Hsieh, Y.S. (2013). Kaempferol reduces matrix metalloproteinase- 2 expression by down-regulating ERK1/2 and the activator protein-1 signaling pathways in oral cancer cells. PLoS One 8, e80883.   DOI
13 Liotta, L.A., Steeg, P.S., and Stetler-Stevenson, W.G. (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64, 327-336.   DOI   ScienceOn
14 Lv, Z., Yang, D., Li, J., Hu, M., Luo, M., Zhan, X., Song, P., Liu, C., Bai, H., Li, B., et al. (2013). Bone morphogenetic protein 9 overexpression reduces osteosarcoma cell migration and invasion. Mol. Cells 36, 119-126   DOI
15 Visse, R., and Nagase, H. (2003). Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92, 827-839.   DOI   ScienceOn
16 Shin, M., Yan, C., and Boyd, D. (2002). An inhibitor of c-jun aminoterminal kinase (SP600125) represses c-Jun activation, DNAbinding and PMA-inducible 92-kDa type IV collagenase expression. Biochim. Biophys. Acta 1589, 311-316.   DOI   ScienceOn
17 Shin, W.S., Maeng, Y.S., Jung, J.W., Min, J.K., Kwon, Y.G., and Lee, S.T. (2008). Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesis. Biochem. Biophys. Res. Commun. 371, 793-798.   DOI   ScienceOn
18 Sivaramakrishnan, V., and Niranjali Devaraj, S. (2009). Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma. Chem. Biol. Interact 180, 353-359.   DOI   ScienceOn
19 Watanabe, H., Nakanishi, I., Yamashita, K., Hayakawa, T., and Okada, Y. (1993). Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J. Cell Sci. 104 (Pt 4), 991-999.
20 Yan, C., and Boyd, D.D. (2007). Regulation of matrix metalloproteinase gene expression. J. Cell Physiol. 211, 19-26.   DOI   ScienceOn
21 Yi, L., Chen, C.Y., Jin, X., Zhang, T., Zhou, Y., Zhang, Q.Y., Zhu, J.D., and Mi, M.T. (2012). Differential suppression of intracellular reactive oxygen species-mediated signaling pathway in vascular endothelial cells by several subclasses of flavonoids. Biochimie 94, 2035-2044.   DOI   ScienceOn
22 Zheng, H., Takahashi, H., Murai, Y., Cui, Z., Nomoto, K., Niwa, H., Tsuneyama, K., and Takano, Y. (2006). Expressions of MMP-2, MMP-9 and VEGF are closely linked to growth, invasion, metastasis and angiogenesis of gastric carcinoma. Anticancer Res. 26, 3579-3583.
23 Phromnoi, K., Yodkeeree, S., Anuchapreeda, S., and Limtrakul, P. (2009). Inhibition of MMP-3 activity and invasion of the MDAMB- 231 human invasive breast carcinoma cell line by bioflavonoids. Acta Pharmacol. Sin. 30, 1169-1176.   DOI   ScienceOn
24 Nam, Y.H., Ryu, E., Lee,D., Shim, H.J., Lee, Y.C., and Lee, S.T. (2011). CagA phosphorylation-dependent MMP-9 expression in gastric epithelial cells. Helicobacter 16, 276-283.   DOI   ScienceOn
25 Nelson, A.R., Fingleton, B., Rothenberg, M.L., and Matrisian, L.M. (2000). Matrix metalloproteinases: biologic activity and clinical implications. J. Clin. Oncol. 18, 1135-1149.   DOI
26 Park, J.H., Jang, Y.J., Choi, Y.J., Jang, J.W., Kim, J.H., Rho, Y.K., Kim, I.J., Kim, H.J., Leem, M.J., and Lee, S.T. (2013). Fisetin inhibits matrix metalloproteinases and reduces tumor cell invasiveness and endothelial cell tube formation. Nutr. Cancer 65, 1192-1199.   DOI   ScienceOn
27 Sartor, L., Pezzato, E., Dell'Aica, I., Caniato, R., Biggin, S., and Garbisa, S. (2002). Inhibition of matrix-proteases by polyphenols: chemical insights for anti-inflammatory and anti-invasion drug design. Biochem. Pharmacol. 64, 229-237.   DOI   ScienceOn
28 Sato, H., and Seiki, M. (1993). Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8, 395-405.
29 Sato, H., Kita, M., and Seiki, M. (1993). v-Src activates the expression of 92-kDa type IV collagenase gene through the AP- 1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem. 268, 23460-23468.
30 Scalbert, A., Manach, C., Morand, C., Remesy, C., and Jimenez, L. (2005). Dietary polyphenols and the prevention of diseases. Crit. Rev. Food Sci. Nutr. 45, 287-306.   DOI   ScienceOn
31 Bond, M., Fabunmi, R.P., Baker, A.H., and Newby, A.C. (1998). Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett. 435, 29-34.   DOI   ScienceOn